| Literature DB >> 18191861 |
Ling-Hong Shen1, Lei Zhou, Bin-Yao Wang, Jun Pu, Liu-Hua Hu, Da-Jun Chai, Li Wang, Jin-Zhang Zeng, Ben He.
Abstract
Dendtritic cells (DCs) are potent antigen-presenting cells and have an important role in the pathogenesis of atherosclerosis. Recent data suggests oxidized low-density lipoprotein (oxLDL) promotes the transition of a differentiating monocyte to a mature dendritic cell. In this study, we examined whether oxLDL could induce the differentiation of mature macrophages into DCs. After 48 h treatment with oxLDL, RAW264.7 cells increased in cell size and exhibited dendritic morphology. At the optimal oxLDL dose (10 microg/ml), approximately 74% of RAW264.7 cells differentiated into dendritic-like cells. Flow cytometric analysis detected dendritic cell surface markers (CD83, CD40, CD86, MHC Class II, and CD1d), and their expression increased in a dose- and time-dependent manner. Moreover, oxLDL-treated RAW264.7 cells showed functional changes including reduced endocytic activity, increased allostimulatory activity, and IL-12 production. The findings of the present work demonstrate that RAW264.7 cells, incubated with oxLDL, acquire some dendritic cell features.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18191861 DOI: 10.1016/j.atherosclerosis.2007.12.002
Source DB: PubMed Journal: Atherosclerosis ISSN: 0021-9150 Impact factor: 5.162